Aptose Biosciences Inc.
Home
About
Overview
Management Team
Board of Directors
Scientific Advisory Board
Product Pipeline
Overview
Tuspetinib for AML
Luxeptinib for B-cell Tumors
Luxeptinib for Myeloid Tumors
Posters & Presentations
Clinical Trials
Overview
Luxeptinib for CLL & NHL
Luxeptinib for AML
Tuspetinib for AML
Expanded Access
News
Press Releases
Presentations
Events
Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
SEDAR
Governance
Join Us
Values & Culture
Perks & Benefits
Explore Careers
Contact
IR Calendar
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
Financial Info
Overview
Financial Results
Income Statement
Cash Flow
Stock Data
NASDAQ: APTO
TSX: APS
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
SEDAR
Governance
Overview
Board of Directors
Board Committees
Governance Documents
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
LifeSci Advisors Corporate Access Event
San Francisco
Jan 9 – Jan 11, 2023
Audio
Webcast
Email Alerts
Contacts
RSS News Feed